Assessing the reliability of a novel cancer-specific multi-attribute utility instrument (FACT-8D) and comparing its validity to EQ-5D-5L in colorectal cancer patients-Reference-Cited by-同舟云学术

Assessing the reliability of a novel cancer-specific multi-attribute utility instrument (FACT-8D) and comparing its validity to EQ-5D-5L in colorectal cancer patients

Published:2024-09-03 Issue: Volume: Page:
ISSN:0962-9343
Container-title:Quality of Life Research
language:en
Short-container-title:Qual Life Res

Author:

Cao Yiyin,Zhang Huan,Luo Nan,Li Haofei,Cheng Ling Jie,Huang Weidong^ORCID

Funder

National Social Science Fund of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11136-024-03774-1.pdf

Reference66 articles.

1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. C Ca: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660

2. Chen, S., Cao, Z., Prettner, K., Kuhn, M., Yang, J., Jiao, L., Wang, Z., Li, W., Geldsetzer, P., Bärnighausen, T., Bloom, D. E., & Wang, C. (2023). Estimates and projections of the Global Economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol, 9(4), 465–472. https://doi.org/10.1001/jamaoncol.2022.7826

3. Van Cutsem, E., Borràs, J. M., Castells, A., Ciardiello, F., Ducreux, M., Haq, A., Schmoll, H. J., & Tabernero, J. (2013). Improving outcomes in colorectal cancer: Where do we go from here? European Journal of Cancer, 49(11), 2476–2485. https://doi.org/10.1016/j.ejca.2013.03.026

4. Färkkilä, N., Torvinen, S., Sintonen, H., Saarto, T., Järvinen, H., Hänninen, J., Taari, K., & Roine, R. P. (2015). Costs of colorectal cancer in different states of the disease. Acta Oncologica, 54(4), 454–462. https://doi.org/10.3109/0284186x.2014.985797

5. Heintz, E., Gerber-Grote, A., Ghabri, S., Hamers, F. F., Rupel, V. P., Slabe-Erker, R., & Davidson, T. (2016). Is there a European view on Health economic evaluations? Results from a synopsis of methodological guidelines used in the EUnetHTA Partner Countries. Pharmacoeconomics, 34(1), 59–76. https://doi.org/10.1007/s40273-015-0328-1